Previous data have highlighted a positive association between MS disease activity (clinical and radiological) and frequency of CD8+ T cells specific for EBV lytic antigens (including BZLF1) in the peripheral blood of patients with relapsing remitting MS [49]. This evidence concerns the gene CD8A and relapsing-remitting multiple sclerosis.